CRISTIAN POPESCU: Open Payments
NPI 1073273777 · FOLSOM, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,226 in 67 payments from 13 companies in 2025. Trend: 2023 $978 · 2024 $1,134 · 2025 $1,226
Food & beverage: $1,226
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $260 |
| Regeneron Healthcare Solutions, Inc. | 8 | $242 |
| Arcutis Biotherapeutics, Inc. | 18 | $202 |
| ABBVIE INC. | 12 | $166 |
| Novartis Pharmaceuticals Corporation | 4 | $86 |
| UCB, Inc. | 3 | $72 |
| Galderma Laboratories, L.P. | 3 | $49 |
| Lilly USA, LLC | 2 | $48 |
| Hill Dermaceuticals, Inc. | 1 | $30 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $20 |
Products named: TREMFYA, DUPIXENT, Zoryve, SKYRIZI, Bimzelx, COSENTYX, Tolak, TALTZ.
Industry payments across CA — which companies pay providers there.
